Hypercoagulability in β-thalassemia: A status quo

Maria Domenica Cappellini, Erika Poggiali, Ali T. Taher, Khaled M. Musallam

Research output: Contribution to journalArticlepeer-review


Life expectancy of thalassemia patients has markedly improved over the last few decades, but patients still suffer from many complications of their congenital chronic disease, and several new complications are now being acknowledged, including thrombosis. The high prevalence of thromboembolic events, especially in thalassemia intermedia, has led to the identification of a hypercoagulable state in these patients. This review summarizes current knowledge of the clinical and pathophysiological characteristics of hypercoagulability in thalassemia patients. Strategies to prevent thrombotic events are also discussed.

Original languageEnglish
Pages (from-to)505-512
Number of pages8
JournalExpert Review of Hematology
Issue number5
Publication statusPublished - Oct 2012


  • coagulopathy
  • hypercoagulability
  • thalassemia intermedia
  • thalassemia major
  • thrombosis

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Hypercoagulability in β-thalassemia: A status quo'. Together they form a unique fingerprint.

Cite this